Monoclonal antibody | |
---|---|
Type | Whole antibody |
Source | Human |
Target | selectin P |
Clinical data | |
Other names | LC1004-002 |
ATC code |
|
Identifiers | |
CAS Number | |
ChemSpider |
|
UNII | |
KEGG | |
Chemical and physical data | |
Formula | C6452H9930N1730O2024S42 |
Molar mass | 145465.02 g·mol−1 |
Inclacumab (LC1004-002) (INN) is a human monoclonal antibody designed for the treatment of cardiovascular disease.[1][2][3][4][5][6][7][8][9]
Monoclonals for bone, musculoskeletal, circulatory, and neurologic systems | |||||||||
---|---|---|---|---|---|---|---|---|---|
Bone |
| ||||||||
Musculoskeletal |
| ||||||||
Circulatory |
| ||||||||
Neurologic |
| ||||||||
Angiogenesis inhibitor |
| ||||||||
Growth factor |
| ||||||||
|